2019-02-28 10:16:41 AM
Promising treatment identified for deadly neuroendocrine prostate cance
2019-02-08 3:10:16 PM
Dr. Amina Zoubeidi, an associate professor at the University of British Columbia is set to change the course of treatment for neuroendocrine prostate cancer (NEPC) – a deadly form of prostate cancer for which there is no effective treatment. She and her team have developed and are testing a drug they hope will be a major breakthrough.
2019-02-01 1:15:44 PM
“Trust me. It’s hard work.” It’s one of the first things Shahroz Ehsan will tell you about the
Step Up Challenge, where teams race up 5,000 steps in downtown office towers, raising awareness and funds to overcome the most common cancer among Canadian men.
2019-02-01 12:51:03 PM
In 1996, two years after its creation, Prostate Cancer Canada awarded its first research grant to Dr. Laurence Klotz and his team at Sunnybrook Health Sciences Centre in Toronto – and its impact surpassed the team’s wildest dreams.
2019-02-01 12:01:14 PM
Between 10-20 per cent of men with prostate cancer can trace their diagnosis back to a gene mutation they inherited from their parents. One such gene is BRCA2. Every man and woman has a BRCA2 gene, but when it is changed, or mutated, their risk of developing breast, ovarian and prostate cancer increases.
2019-02-01 11:36:00 AM
Would you ever guess that urine might hold the key to better prostate cancer treatments? Dr. Bharati Bapat, a cancer geneticist at Mount Sinai Hospital in Toronto, is doing just that: Using patients’ urine to predict who is likely to develop different types of prostate cancer.